Cite
MLA Citation
W Reinisch et al.. “A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon γ antibody, in patients with moderate to severe Crohn's disease.” Gut, vol. 55, no. 8, 2006, pp. 1138–1144. http://access.bl.uk/ark:/81055/vdc_100135558078.0x00004a